Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 54,475 | 52,436 | 46,007 | 59,077 | 80,542 |
| Cost of Goods | 12,173 | 12,301 | 10,556 | 13,921 | 29,097 |
| Gross Profit | 42,302 | 40,135 | 35,451 | 45,156 | 51,445 |
| Operating Expenses | 32,902 | 33,800 | 32,023 | 32,712 | 29,463 |
| Operating Income | 9,573 | 6,636 | 3,984 | 13,365 | 22,079 |
| Interest Expense | 1,489 | 1,837 | 2,177 | 2,621 | 3,100 |
| Other Income | 1,159 | 1,366 | 1,460 | 1,494 | 1,629 |
| Pre-tax Income | 9,243 | 6,165 | 3,267 | 12,238 | 20,608 |
| Income Tax | 399 | 310 | 293 | -7,067 | 291 |
| Net Income Continuous | 8,844 | 5,855 | 2,974 | 19,305 | 20,317 |
| Net Income | $8,844 | $5,855 | $2,974 | $19,305 | $20,317 |
| EPS Basic Total Ops | 0.18 | 0.12 | 0.06 | 0.40 | 0.41 |
| EPS Basic Continuous Ops | 0.18 | 0.12 | 0.06 | 0.40 | 0.41 |
| EPS Diluted Total Ops | 0.17 | 0.12 | 0.06 | 0.40 | 0.41 |
| EPS Diluted Continuous Ops | 0.17 | 0.12 | 0.06 | 0.40 | 0.41 |
| EPS Diluted Before Non-Recurring Items | 0.17 | 0.12 | 0.06 | 0.39 | 0.41 |
| EBITDA(a) | $12,295 | $9,399 | $6,780 | $16,206 | $24,957 |